Feature Channels: Liver Disease

Filters close
Released: 21-Feb-2024 2:05 PM EST
Study examines medical mystery of child hepatitis outbreak
University of Sydney

A world-first analysis of a sudden global outbreak of hepatitis in children finds although the primary suspect is highly likely to be an infection by multiple viruses, many questions still puzzle researchers.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

Released: 13-Feb-2024 11:05 AM EST
Life doesn't stop at age 65. Get the latest on seniors and healthy aging in the Seniors channel
Newswise

Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.

Released: 13-Feb-2024 9:00 AM EST
Mount Sinai Researchers Receive $5 Million Gift From the Blavatnik Family Foundation to Expand Revolutionary Organ Perfusion Platform
Mount Sinai Health System

The Mount Sinai Recanati/Miller Transplantation Institute has received a $5 million gift from the Blavatnik Family Foundation, pledged across five years.

Newswise: Chula Researcher’s Innovative Wireless Hepatitis B Test Kit for Complete Screening and Data Collection in One Step
Released: 13-Feb-2024 8:55 AM EST
Chula Researcher’s Innovative Wireless Hepatitis B Test Kit for Complete Screening and Data Collection in One Step
Chulalongkorn University

Chula researchers have developed a remarkable wireless hepatitis B virus test kit to screen for infection and collect data for an online database that’s fast and complete in one step.

Released: 9-Feb-2024 3:05 PM EST
This ultrasound sticker senses changing stiffness of deep internal organs
Massachusetts Institute of Technology (MIT)

MIT engineers have developed a small ultrasound sticker that can monitor the stiffness of organs deep inside the body.

   
Newswise: The Rising Costs of Alcohol-Associated Liver Disease and More in the February Issue of AJG
Released: 8-Feb-2024 8:00 AM EST
The Rising Costs of Alcohol-Associated Liver Disease and More in the February Issue of AJG
American College of Gastroenterology (ACG)

A modeling study projecting the economic and social burden of alcohol-associated liver disease by 2040 is featured in the February 2024 issue of AJG, just one month after the new ACG Clinical Guideline on Alcohol-Associated Liver Disease

Newswise:Video Embedded males-born-to-obese-mothers-more-likely-to-suffer-health-issues-as-adults
VIDEO
Released: 5-Feb-2024 8:05 PM EST
Males born to obese mothers more likely to suffer health issues as adults
University of South Australia

Males born to obese women are more likely to be overweight at birth and develop metabolic complications in later life, including liver disease and diabetes.

Released: 5-Feb-2024 9:30 AM EST
UChicago Medicine among the first to offer histotripsy for liver tumors
University of Chicago Medical Center

UChicago Medicine was the first hospital in Illinois to treat patients using histotripsy, a new noninvasive technology that uses ultrasound energy to precisely destroy liver tumors.

Newswise: 1920_gettyimages-532331964.jpg?10000
Released: 2-Feb-2024 11:05 AM EST
A Record Year for Cedars-Sinai Transplant Patients
Cedars-Sinai

The Cedars-Sinai Comprehensive Transplant Center and Smidt Heart Institute together completed 652 solid organ transplants in 2023, far outpacing Cedars-Sinai’s internal record set just one year ago, when surgeons completed 583 transplants.

Newswise:Video Embedded live-event-nurses-the-most-trusted-profession-in-an-age-of-mistrust
VIDEO
Released: 1-Feb-2024 5:00 PM EST
VIDEO AND TRANSCRIPT: Nurses -- The Most Trusted Profession in an Age of Mistrust
Newswise

For 21 years, nurses have consistently been the most trusted profession, according to the yearly Gallup poll. (The new poll will be issued by the end of January). Dr Rushton, who specializes in burnout, will speak on trust, moral injury, and how nurses cope in this day and age.

Newswise: Record year for the Vanderbilt Transplant Center saves 739 lives
Released: 1-Feb-2024 2:05 PM EST
Record year for the Vanderbilt Transplant Center saves 739 lives
Vanderbilt University Medical Center

The Vanderbilt Transplant Center (VTC) established a new record in calendar year 2023 for total solid organ transplants, performing 739 lifesaving procedures among its adult and pediatric organ transplant programs.

Newswise: UNC Hospitals Performs First Domino Liver Transplant in Decades
Released: 1-Feb-2024 10:05 AM EST
UNC Hospitals Performs First Domino Liver Transplant in Decades
University of North Carolina Health Care System

Chirag Desai, MD, FACS, an abdominal organ transplant and hepatobiliary-pancreatic surgeon at UNC Hospitals, performed a “domino” liver transplant, which helped two patients from a single donor without splitting a liver.

Released: 30-Jan-2024 2:05 PM EST
Our winter of discontent: Get the latest news on the flu in the Influenza channel
Newswise

The latest research and expertise on the flue can be found in the Influenza channel on Newswise.

Newswise: RWJBarnabas Health and Rutgers Cancer Institute of New Jersey First in State offering Novel form of Liver Cancer Treatment
Released: 30-Jan-2024 2:05 PM EST
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey First in State offering Novel form of Liver Cancer Treatment
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey, the state's only National Cancer Institute-designated Comprehensive Cancer Center, together with RWJBarnabas Health, has joined a select number of institutions nationwide that offer a specialized chemotherapy delivery system called hepatic artery infusion (HAI) therapy for patients with liver tumors.

Newswise: Advancing noninvasive diagnosis of NASH: potential of sequential USMI in NAFLD/MAFLD
Released: 26-Jan-2024 8:05 AM EST
Advancing noninvasive diagnosis of NASH: potential of sequential USMI in NAFLD/MAFLD
Chinese Academy of Sciences

Noninvasive non-alcoholic steatohepatitis (NASH) assessment is a clinical challenge in managing non-alcoholic fatty liver disease.

Newswise: Study: Women With Alcohol-Related Liver Disease Have Greater Mortality Risk Than Men With Condition
Released: 25-Jan-2024 11:05 AM EST
Study: Women With Alcohol-Related Liver Disease Have Greater Mortality Risk Than Men With Condition
Cedars-Sinai

Investigators from the Smidt Heart Institute at Cedars-Sinai and colleagues found that women with fatty liver disease related to alcohol consumption have almost twice the risk of dying within a certain time period than men with the same condition.

Newswise: A new 3D bioprinted model offers a novel tool to study common liver disease, and perhaps find an effective treatment
Released: 23-Jan-2024 11:05 AM EST
A new 3D bioprinted model offers a novel tool to study common liver disease, and perhaps find an effective treatment
Sanford Burnham Prebys

Metabolic dysfunction–associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis) is an inflammatory, liver-scarring disease that affects 1.5% to 6.5% of all U.S. adults.

Newswise: Cedars-Sinai Cancer 2023 Research and Program Highlights
Released: 19-Jan-2024 3:05 PM EST
Cedars-Sinai Cancer 2023 Research and Program Highlights
Cedars-Sinai

A roundup of 2023 medical discoveries and innovations at Cedars-Sinai Cancer.

Released: 19-Jan-2024 1:05 PM EST
Don't wait for an emergency to get the latest emergency medicine news
Newswise

Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.

       
Newswise: RUDN biologists: green tea mitigates the harm from hookah
Released: 16-Jan-2024 4:05 AM EST
RUDN biologists: green tea mitigates the harm from hookah
Scientific Project Lomonosov

RUDN University biologists and colleagues from Jordan and Malaysia found that a flavonoid from green tea mitigates the harmful effects of hookah smoking - it reduces inflammation and oxidative stress while protecting the tissues of the lungs, liver, and kidneys.

Released: 11-Jan-2024 8:50 AM EST
mRNA technology could be possible treatment for rare diseases
University College London

The research, published in Science Translational Medicine, found that messenger RNA (mRNA) could be used to correct a rare liver genetic disease known as argininosuccinic aciduria in a mouse model of the disease.

9-Jan-2024 8:05 AM EST
Scientists behind Novel Discoveries and Individuals Leading the Understanding of Emerging Areas of Concern for Public Health Are Being Honored with 2024 SOT Awards
Society of Toxicology

Among the accomplishments of this year’s awardees are discoveries related to the role of altered pharmacokinetics in non-alcoholic fatty liver disease, the mechanisms of Parkinson’s disease neurodegeneration, the risk of COVID-19 to smokers and vapers, and the role of the microbiome in pregnancy and early developmental programming.

   
Newswise: New ACG Guideline on Alcohol-Associated Liver Disease and More in the January Issue of AJG
Released: 10-Jan-2024 8:50 AM EST
New ACG Guideline on Alcohol-Associated Liver Disease and More in the January Issue of AJG
American College of Gastroenterology (ACG)

A new ACG Clinical Guideline on alcohol-associated liver disease (ALD) is featured in the January 2024 issue of The American Journal of Gastroenterology.

6-Jan-2024 7:05 PM EST
Hepatitis Linked to Alcohol Increasingly Drove Emergency Department Visits, Especially Among Younger Adults, In Recent Years
Research Society on Alcoholism

Hepatitis linked to alcohol, the most severe form of alcohol-associated liver disease, is increasingly prevalent, severe, and likely to involve emergency departments, according to a new analysis.

     
Newswise: Understanding How Gut Bacteria Affect Chronic Liver Diseases
Released: 4-Jan-2024 7:05 AM EST
Understanding How Gut Bacteria Affect Chronic Liver Diseases
Chinese Academy of Sciences

The gut microbiome, consisting of trillions of bacteria, viruses, and fungi, plays a crucial role in digestion, nutrient absorption, and the regulation of host metabolism and immunity.

Newswise: Children’s Hospital Los Angeles Performs 500th Liver Transplant
Released: 3-Jan-2024 11:05 AM EST
Children’s Hospital Los Angeles Performs 500th Liver Transplant
Children's Hospital Los Angeles

Children’s Hospital Los Angeles has performed its 500th liver transplant—a milestone achievement that only a handful of pediatric centers in the country have reached.

Released: 20-Dec-2023 3:05 PM EST
Working with Big Data requires a lot of power! The latest research and features on Supercomputing
Newswise

With the rise in machine learning applications and artificial intelligence, it's no wonder that more and more scientists and researchers are turning to supercomputers. Supercomputers are commonly used for making predictions with advanced modeling and simulations. This can be applied to climate research, weather forecasting, genomic sequencing, space exploration, aviation engineering and more.

       
Released: 19-Dec-2023 4:00 PM EST
Inhaled Toxicants, Alternatives to Animal Testing, and Liver Carcinogens Are Spotlighted in ToxSci Journal
Society of Toxicology

The December 2023 issue of ToxSci features a Contemporary Review exploring lipid mediator–driven inflammation following air pollution exposure, an In-Depth Review on the state of in vitro skin models, and ToxSpotlights on the effects of inhalation exposure to TCE and the dose-response assessment of non-mutagenic liver carcinogens.

Released: 15-Dec-2023 3:05 PM EST
Microbiome insights found in poop help predict infections in liver transplant patients
University of Chicago Medical Center

Researchers at UChicago were able to predict postoperative infections in liver transplant patients by analyzing molecules in their poop — a key leap forward in exploring the connection between the gut microbiome and overall health.

Newswise: Silent Carriers: Long-Standing SARS-CoV-2 RNA in Respiratory Vesicles
Released: 14-Dec-2023 10:05 AM EST
Silent Carriers: Long-Standing SARS-CoV-2 RNA in Respiratory Vesicles
Chinese Academy of Sciences

SARS-CoV-2 persists in the respiratory tract, notably in patients with underlying co-morbidities including liver disease.

Released: 13-Dec-2023 12:00 PM EST
MD Anderson Research Highlights for December 13, 2023
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.

   
Newswise: Cancer Discovery: How the Liver Defends Itself
Released: 12-Dec-2023 10:05 AM EST
Cancer Discovery: How the Liver Defends Itself
Cedars-Sinai

Cedars-Sinai investigators have discovered how the liver defends itself against cancer. Their study, published in the peer-reviewed Journal of Hepatology, suggests targets for therapies to protect the liver both from cancers that originate there and cancers that spread to the liver from other parts of the body.

Newswise: Sexual and Gender Minorities in GI Research, Women’s Health Included in the December Issue of AJG
Released: 11-Dec-2023 9:00 AM EST
Sexual and Gender Minorities in GI Research, Women’s Health Included in the December Issue of AJG
American College of Gastroenterology (ACG)

In the December issue of AJG: assisted reproductive technology among women with liver disease, strategies for incorporating sexual and gender minorities in GI research, anxiety/depression in GERD patients, and more.

Newswise: After Multiple Organ Transplants, Grateful for 25 Extra Years
Released: 22-Nov-2023 10:05 AM EST
After Multiple Organ Transplants, Grateful for 25 Extra Years
Cedars-Sinai

This Thanksgiving marks a little more than 25 years since Christine Galan became the first person in the Western U.S. to have a combined organ transplant (heart and liver), and nearly five years since she returned to Cedars-Sinai for another organ transplant—this time, a kidney.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Newswise: RUDN Doctor Clarify Role of Spleen for Diseased Liver
Released: 16-Nov-2023 6:05 AM EST
RUDN Doctor Clarify Role of Spleen for Diseased Liver
Scientific Project Lomonosov

Researchers at the Research Institute of Molecular and Cellular Medicine of RUDN University have found that with significant damage to the liver, the spleen begins to actively help its neighbor in the abdominal cavity. It shares immune cells and triggers anti-inflammatory processes.

Released: 15-Nov-2023 10:05 AM EST
Fatty liver disease gets a new name
University of Chicago Medical Center

The former Metabolic and Fatty Liver Clinic at the University of Chicago Medicine is undergoing a name change, as part of a shift in language to drop stigmatizing words, precisely describe the condition and identify a subgroup of patients omitted under the former diagnostic criteria.

Newswise: image.jpg
Released: 14-Nov-2023 9:05 AM EST
Pioneering histotripsy device receives FDA clearance to treat liver cancer
Virginia Tech

In a groundbreaking achievement for cancer treatment, research, and medical technology, the U.S. Food and Drug Administration (FDA) has granted approval for the HistoSonics’ Edison histotripsy device to treat liver tumors. 

Released: 25-Oct-2023 5:05 PM EDT
Oregon State researchers uncover mechanism for treating dangerous liver condition
Oregon State University

A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved medications.

Newswise: New Cancer Therapy Target Stops Tumor Cells From Sharing Resources
Released: 17-Oct-2023 9:00 AM EDT
New Cancer Therapy Target Stops Tumor Cells From Sharing Resources
University of California San Diego

Researchers at University of California San Diego have discovered a process in which liver cells share molecules in order to multiply under conditions that would ordinarily suppress cell proliferation. They also found evidence that this process occurs in various types of cancer cells.

Newswise:Video Embedded tumor-destroying-soundwaves-receive-fda-approval-for-liver-treatment-in-humans
VIDEO
Released: 13-Oct-2023 8:05 AM EDT
Tumor-destroying soundwaves receive FDA approval for liver treatment in humans
Michigan Medicine - University of Michigan

The U.S. Food and Drug Administration has approved the use of sound waves to break down tumors—a technique called histotripsy—in humans for liver treatment.

Newswise: New study unveils the novel factor FGF18 as a pivotal driver of liver fibrosis
Released: 11-Oct-2023 5:05 PM EDT
New study unveils the novel factor FGF18 as a pivotal driver of liver fibrosis
Toho University

Liver fibrosis is associated with various liver injuries, including viral infection, inflammation, excess alcohol consumption, and metabolic dysfunction.

Released: 2-Oct-2023 10:05 AM EDT
Multi-omics research on liver disease in Hispanics/Latinos funded through $4M NIH grant to UTHealth Houston
University of Texas Health Science Center at Houston

As one of just six sites in the country chosen for a new consortium of the National Institutes of Health (NIH), UTHealth Houston School of Public Health in Brownsville will use multi-omics in combination with environmental, epidemiologic, and clinical data, along with social determinants of health, to study non-alcoholic and non-viral liver disease in Hispanics/Latinos.

Released: 27-Sep-2023 1:05 PM EDT
Genetic variation with MASLD reveals subtypes and potential therapeutic avenues
Michigan Medicine - University of Michigan

A study reveals genetic subtypes, biomarkers, gene and pathway targets for the development of new treatments for this liver disease

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Newswise: Research identifies new potential hurdle for nano-based therapies
17-Sep-2023 8:00 PM EDT
Research identifies new potential hurdle for nano-based therapies
University of Texas MD Anderson Cancer Center

Researchers at The University of Texas MD Anderson Cancer Center have discovered that certain nano-based cancer therapies may be less effective in younger patients, highlighting the need for further investigation into the impact of aging on the body’s ability to respond to treatment.

Released: 11-Sep-2023 12:05 PM EDT
Alerta para los expertos: Expertos advierten sobre la enfermedad hepática silenciosa que crece entre hispanos y niños
Mayo Clinic

La cirrosis a menudo es consecuencia del consumo de alcohol crónico a largo plazo. Sin embargo, algunas personas que consumen poco o nada de alcohol pueden presentar cirrosis.

Released: 11-Sep-2023 11:05 AM EDT
Opinião de especialistas: O avanço silencioso de uma doença do fígado entre hispânicos e crianças é preocupante
Mayo Clinic

A cirroseé geralmente associada ao consumo prolongado e excessivo de álcool. No entanto, algumas pessoas que consomem pouco ou nenhum álcool podem acabar desenvolvendo a doença.



close
1.1819